Managing interstitial lung disease: impact of involving a specialist respiratory pharmacist

Interstitial lung disease (ILD) is an umbrella term describing a diverse group of lung diseases that result in impairment or fibrosis of the alveolar interstitium. Idiopathic interstitial pneumonias are the most common ILDs; and idiopathic pulmonary fibrosis (IPF) is most common among this cohort of patients. Symptoms of ILD include breathlessness and a persistent, dry and irritating cough. Patients with ILD may experience acute exacerbations, which can increase the burden of disease, ...
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research